Juvenile idiopathic arthritis
M Sudhakar, S Kumar - Indian Journal of Pediatrics, 2024 - Springer
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The
International League of Associations for Rheumatology (ILAR) has defined JIA as “arthritis of …
International League of Associations for Rheumatology (ILAR) has defined JIA as “arthritis of …
Juvenile idiopathic arthritis
Juvenile idiopathic arthritis is the most common chronic rheumatic disease of unknown
aetiology in childhood and predominantly presents with peripheral arthritis. The disease is …
aetiology in childhood and predominantly presents with peripheral arthritis. The disease is …
Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single‐center experience
Aim Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of JIA characterized
by systemic features and poor outcome. We aimed to investigate demographic and clinical …
by systemic features and poor outcome. We aimed to investigate demographic and clinical …
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease
J Sota, D Rigante, P Ruscitti, A Insalaco… - Frontiers in …, 2019 - frontiersin.org
Background and Objective: Only a few studies have reported long-term efficacy of interleukin
(IL)-1 inhibition in systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still disease …
(IL)-1 inhibition in systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still disease …
Evaluating treatment practices and challenges in systemic Juvenile Idiopathic Arthritis: a comprehensive survey analysis
X Tan, X Zhao, J Deng, C Li, J Zhang, S Li, C Li - Clinical Rheumatology, 2024 - Springer
Objective This study aims to assess current diagnostic and management for systemic
Juvenile Idiopathic Arthritis (sJIA) among physicians, evaluate the challenges encountered …
Juvenile Idiopathic Arthritis (sJIA) among physicians, evaluate the challenges encountered …
Tocilizumab in systemic juvenile idiopathic arthritis: response differs by disease duration at medication initiation and by phenotype of disease
X Yan, W Tang, Z Zhang, Y Zhang, C Luo… - Frontiers in …, 2021 - frontiersin.org
Objective: We performed a single-center retrospective study to determine the different
efficacy of tocilizumab (TCZ) in the early and late stages and in three phenotypic subgroups …
efficacy of tocilizumab (TCZ) in the early and late stages and in three phenotypic subgroups …
Dental age estimation in children affected by juvenile rheumatoid arthritis
V Pinchi, I Bianchi, F Pradella, G Vitale… - International Journal of …, 2021 - Springer
Dental root calcification has proven to be a reliable biological evidence to estimate
chronological age of children. The development of structures usually examined in the age …
chronological age of children. The development of structures usually examined in the age …
Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis
J Sota, A Insalaco, R Cimaz, M Alessio… - Frontiers in …, 2019 - frontiersin.org
Background and Objectives: Few studies have reported the drug retention rate (DRR) of
biologic drugs in juvenile idiopathic arthritis (JIA), and none of them has specifically …
biologic drugs in juvenile idiopathic arthritis (JIA), and none of them has specifically …
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study
W Zhan, J Yang, L Qiu, K Yang, X Ye… - Pediatric …, 2024 - Springer
Background Interstitial lung disease (ILD) is a serious complication in systemic juvenile
idiopathic arthritis (SJIA). This study aimed to identify the clinical characteristics and …
idiopathic arthritis (SJIA). This study aimed to identify the clinical characteristics and …
Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein–Barr …
Y Zhao, Z Li, L Zhang, H Lian, H Ma, D Wang, X Zhao… - Medicine, 2020 - journals.lww.com
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In clinical practice,
we have observed that some HLH patients who have features of systemic autoinflammatory …
we have observed that some HLH patients who have features of systemic autoinflammatory …